In biopharmaceutical development and advanced life science research, an efficient, reliable, and flexible bioreactor platform is essential for accelerating process development and commercialization. Bioengineering Taberis Bioreactor Series is designed to address these needs by delivering reliable performance, intelligent control, and scalable solutions across different stages of bioprocess development. From high-throughput parallel screening to production-oriented precision control, the Taberis portfolio supports bioprocess innovation with a comprehensive range of bioreactor solutions tailored for R&D and manufacturing applications.
1.Taberis Parasmart Parallel Bioreactor
The fastest way to reliable data.
Parallelism is not just a method. It is the key to efficiency in research an development.
• Greatly improved experimental efficiency
• Excellent parallelism and repeatability
• Reduced reagent consumption and cost
• Facilitates rapid condition screening and process optimization
• High automation and reliable data
Fast and reliable process screening
The Taberis Parasmart is a high-performance parallel bioreactor designed for high-throughput applications, enabling multiple independent processes to run simultaneously. This parallel operation allows for particularly rapid screening of different experimental conditions and supports efficient process optimization in research and development. Thanks to its high level of automation, precise data acquisition, and the ability to allocate resources strategically, the Taberis Parasmart ensures reliable results, increased productivity, and a significant increase in experimental efficiency.
Complexity that feels simple
The software enables intuitive and unified control of multiple systems and supports real-time monitoring of all relevant process parameters.
A central control unit with a large screen clearly displays all operating data, while a small integrated control screen allows for easy adjustment of key parameters. Precise cascade control and automated recipe execution ensure high reproducibility and efficient process development.
2. Taberis Prime Benchtop Bioreactor
The compact solution for everyday lab work.
Taberis PrimeⅠ
• Cost-effective entry into bioprocess technology
• High oxygen transfer rate
• In-situ sterilizable
• Closed harvesting and transfer possible
High performance right from the start
The Taberis Prime I benchtop bioreactor was developed for applications where high performance and production-oriented processes are key. Its streamlined design enables simple and reliable operation while providing a cost-effective entry point into bioprocess technology. The integrated in-situ sterilization of the vessel and bottom drain ensures production-ready processes.
The bottom-mounted drive with high power input ensures an exceptionally high oxygen transfer rate. The system is particularly well-suited for applications in research, education, and early development and pilot phases in the pharmaceutical and biotechnology industries.
Taberis Prime A
• Cost-effective entry into bioprocess technology
• Compact design for optimal use of space
• Intuitive operation and easy handling
Quickly achieve a stable process
The Taberis Prime A benchtop bioreactor was developed for applications where efficiency and reproducibility are key. Its design, focused on the essentials, enables simple and reliable operation while laying the foundation for a cost effective entry into bioprocess technology. Autoclave sterilization integrates seamlessly into established laboratory workflows.
The result is a system that impresses with its clarity, stability, and ease of use, providing reliable support especially for users in training, research, and smaller pharmaceutical and biotech environments. A well-designed solution for efficient work and consistent results.
3. Taberis Xpert Benchtop Bioreactor
For maximum flexibility and performance.
Taberis XpertⅠ
• Modularly expandable for demanding processes
• High oxygen transfer rate
• Can be sterilized in situ
• Closed harvesting and transfer possible
When production-scale operations and high performance are required
The Taberis Xpert I is a highly flexible benchtop bioreactor for demanding Batch, fed-batch, and perfusion processes. As a comprehensive Xpert version, it enables precise control of all relevant process parameters. In-situ sterilization of the vessel and bottom drain enables production-oriented operations. The bottom drive with high power input ensures an exceptionally high oxygen transfer rate.
Thanks to its high flexibility, the system demonstrates its strengths in a wide variety of processes and ensures consistently high-quality results, particularly in the fields of research and development as well as in the pharmaceutical and biotechnology industries.
Taberis Xpert A
• Modularly expandable for demanding processes
• Quick and intuitive recipe editing
• GMP-compliant design
• Space-saving design for any laboratory
Harness the full potential of your processes
The Taberis Xpert A is a highly flexible benchtop bioreactor for demanding Batch, fed-batch, and perfusion processes that require maximum control and flexibility. As a comprehensive Xpert model, it enables precise control of all relevant process parameters, thereby laying the foundation for stable and reproducible results. Autoclave sterilization ensures proven and flexible handling in everyday laboratory work.
The system can be easily adapted for different processes and supports users in the pharmaceutical, biotechnology, startup, and research sectors in reliably and efficiently meeting complex requirements. The Taberis Xpert A thus offers an advanced platform for development, production, and versatile applications with the necessary reliability for reproducible results.
BioScada II – Intuitive SCADA for controlling bioprocesses
Both the Taberis Prime and Taberis Xpert series are powered by the BioScada II system. BioScada II visualizes and analyzes your bioprocess in real time. Freely configurable widgets display critical process parameters, trends and system states exactly where they are needed. Integrated analysis tools enable fast comparison of batches and support data-driven process optimization.
• Freely configurable widgets for process visualization
• Integrated analyzer with batch-tobatch trend comparison
• Setpoint Selector for intuitive cascade control configuration
• Flexible setpoint profiles (e.g. exponential feed strategies)
• Integrated sequencer for custom process workflows
• Remote Service Provider for secure system monitoring and support
Whether supporting high-throughput screening for greater efficiency or precision-controlled processes that meet demanding production requirements, the Bioengineering Taberis Series combines high-performance hardware with intelligent software designed around user needs. From cost-effective entry-level solutions to versatile production-grade platforms, Taberis is more than a portfolio of instruments—it is a reliable partner that helps researchers and industry professionals shorten development timelines, enhance process consistency, and accelerate commercialization. Choose Taberis to make every bioprocess development program more precise, efficient, and ready for the future.
About Bioengineering AG
Bioengineering AG is a global leader in bioreactor technology. With over 50 years of dedicated expertise, the company has built a strong international reputation for professional excellence. Today, Bioengineering AG serves clients worldwide, offering comprehensive solutions that cover the full spectrum of bioreaction and cultivation needs—from laboratory research and pilot-scale development to commercial-scale production. In 2025, Bioengineering AG officially joined the Morimatsu. By synergizing its deep technological foundation with collaborative innovation, the company is committed to driving high-quality, sustainable development across the pharmaceutical, biopharmaceutical, and synthetic biology industries.
About Morimatsu LifeSciences
Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.
Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.
Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.
Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.
As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.
